Author:
Vitellius Carole,Eymerit-Morin Caroline,Luet Dominique,Fizanne Lionel,Foubert Fanny,Bertrais Sandrine,Rousselet Marie-Christine,Caroli-Bosc François-Xavier
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference39 articles.
1. Conroy T, Desseigne F, Ychou M, Groupe Tumeurs Digestives of Unicancer, PRODIGE Intergroup, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817–25.
2. Spratlin JL, Mulder KE. Looking to the future: biomarkers in the management of pancreatic adenocarcinoma. Int J Mol Sci. 2011;12:5895–907.
3. Konecny GE, Kristeleit RS. PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions. Br J Cancer. 2016;115:1157–73.
4. Esteller M, Hamilton SR, Burger PC, et al. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 1999;59:793–7.
5. Sabharwal A, Middleton MR. Exploiting the role of O6-methylguanine-DNA methyltransferase (MGMT) in cancer therapy. Curr Opin Pharmacol. 2006;6:355–63.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献